Skip to content

Clinical trials

Phase 1 Lupus Erythematosus, Systemic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20181
20232
20241
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed3
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2
AbbVie1
AstraZeneca1
Bristol-Myers Squibb1
Cullinan Therapeutics Inc.1
Fate Therapeutics1
Genentech, Inc.1
GlaxoSmithKline1
Gustave Roussy, Cancer Campus, Grand Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic15
Myositis7
Arthritis, Rheumatoid6
Scleroderma, Systemic5
Lupus Nephritis4
Autoimmune Diseases3
Dermatomyositis3
Dry Eye Syndromes2
Musculoskeletal Diseases2
Polymyositis2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.